The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for ALCOR Scientific sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
ALCOR Scientific is a medical device company that designs and manufactures innovative diagnostic instrumentation to reduce the time required for erythrocyte sedimentation rate testing. The company’s iSED technology offers quick ESR results. Its products and solutions modernize the traditional processes and procedures, improving their efficiency, workflow and cost efficiency. The company’s products including ised, miniised, seditrol and sentinelplus improve laboratory efficiency. The company distributes its products through a network of both domestic and international distributors. ALCOR Scientific is headquartered in Rhode Island, the US.
The key metrics of ALCOR Scientific related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As ALCOR Scientific is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as ALCOR Scientific.
For a detailed understanding of the performance of ALCOR Scientific, buy the report here.